To observe the stability of stable nAMD patients treated with PRN and T&E protocol of anti-VEGF treatment when they recovered from discontinued treatment affected by COVID-19 outbreak : To observe the stability of stable nAMD patients treated with PRN and T&E protocol of anti-VEGF treatment when they recovered from discontinued treatment affected by COVID-19 outbreak

Medienart:

Klinische Studie

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

WHO International Clinical Trials Registry Platform - (2021) vom: 21. Dez. Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: neovascular age-related macular degeneration
Phase: Retrospective study
Recruitment Status: Completed
Study Type: Observational

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2021-05-07, Last updated: 2022-11-24

ICTRP ID:

ChiCTR2100046164

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

CTG008093407